Wednesday 9 October 2013

Molidustat (BAY 85-3934), Bayer’s drug under initiation in patients with anemia associated with chronic kidney disease and/or end-stage renal disease. « New Drug Approvals

Molidustat (BAY 85-3934), Bayer’s drug under initiation in patients with anemia associated with chronic kidney disease and/or end-stage renal disease. « New Drug Approvals:

'via Blog this'

No comments:

Post a Comment